The procedure known as minimally invasive extreme lateral interbody fusion (XLIF) is used to treat degenerative disc disease (DDD), degenerative spondylolisthesis and degenerative scoliosis. Unlike most mid to low back spine surgery, which involves the large muscles in the middle of your back and avoiding large muscle groups. Direct Lateral Interbody Fusion or DLIF, is a minimally invasive surgical procedure used to treat degenerative disc disease-related leg or back pain. Unlike traditional anterior or posterior approaches to back surgery, DLIF enters the lumbar spine from the side of the patient.
Data Bridge Market Research analyses that the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market which is expected to grow at a healthy CAGR during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Sample PDF Report: –https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-direct-lateral-interbody-fusion-dlif-and-extreme-lateral-interbody-fusion-xlif – Implant market
Some of the major players operating in the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market are:
Medtronic (Ireland) NuVasive, Inc. (U.S.) Stryker (U.S.) Medical Devices Business Services, Inc. (U.S.) Zimmer Biomet (U.S.) Globus Medical (U.S.) Orthofix US LLC. (U.S.) ATech Spine, Inc. (U.S.) Osseous Surgicals (India) Captiva Spine, Inc. (U.S.) S. H. Pitkar Orthotools Pvt. Ltd. (India) Gesco Healthcare Pvt. Ltd. (India) Sharma Orthopedic (India) Jayon Implants (India) Implants International (U.K.) Global Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Dynamics
Drivers
Rising usage of direct lateral interbody fusion The direct lateral interbody fusion (DLIF), a minimally invasive lateral approach for placement of an interbody fusion device, does not require nerve root retraction or any contact with the great vessels and can lead to short operative times with little blood loss. This procedure has not been used at the lumbosacral (L5-S1) junction due to the anatomical restrictions. Lumbosacral transitional vertebrae (LSTV), a structural anomaly of the lumbosacral spine associated with low back pain, can result in a level being wrongly identified pre-operatively due to misnumbering of the vertebral levels. These are the certain factors which propel the growth of the market.
Rising minimally invasive procedures Extreme lateral interbody fusion (XLIF) is a minimally invasive procedure performed through the side of the body to treat spinal disorders and relieve chronic back or leg pain that has not responded to other treatments such as steroid injections, physical therapy, and pain medication. The minimally invasive extreme lateral interbody fusion (XLIF) procedure allows the doctor to avoid major large muscle groups in the centre of the back while removing the damaged disc. The muscles are not severed, rather they are separated gently to allow the spine surgeon access to the spine and the damaged disc. After removing the damaged disc, a small plastic cage filled with bone material is placed between the vertebrae. These are the factors which propel the growth of the market.
Opportunities
Rising RD activities Rising RD activities for spine surgery that is XLIF, which typically takes about an hour and performed under general anesthesia, the surgeon accesses the space between each spinal disc from the patient’s side, rather than the front or back, sparing major back muscles, bones, and ligaments. It will provide ample opportunities for the growth of the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market during the forecast period.
For More Market Analysis Information, Explore Research Report Summary @:- https://www.databridgemarketresearch.com/reports/global-direct-lateral-interbody-fusion-dlif-and-extreme-lateral-interbody-fusion-xlif-implants-market
Global Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Scope
The direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market is segmented on the basis of indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
Degenerative Disc Diseases Spondylolisthesis Scoliosis Others End User
Ambulatory Surgical Units Hospitals Clinics Others Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) Implants Market Regional Analysis/Insights
The direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market is analysed and market size insights and trends are provided by country, indication and end user as referenced above. The countries covered in the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the direct lateral interbody fusion (DLIF) and eXtreme lateral interbody fusion (XLIF) implants market due to due to the growing occurrences of spinal injuries along with improved healthcare facilities and prevalence of geriatric population. Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to rising popularity of medial tourism and the development of improved infrastructure.
Explore Complete TOC at:– https://www.databridgemarketresearch.com/toc/?dbmr=global-direct-lateral-interbody-fusion-dlif-and-extreme-lateral-interbody-fusion-xlif-implants-market
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Top Healthcare Report Links:-
https://www.databridgemarketresearch.com/reports/europe-lentiviral-vector-market
https://www.databridgemarketresearch.com/reports/asia-pacific-lentiviral-vector-market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-lentiviral-vector-market
https://www.databridgemarketresearch.com/reports/north-america-lentiviral-vector-market
https://www.databridgemarketresearch.com/reports/global-laboratory-hoods-and-enclosure-market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting company with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and providing effective insights for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a body of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has over 500 analysts working across different industries. We have served over 40% of Fortune 500 companies globally and have a network of over 5,000 clients worldwide. Data Bridge knows how to create satisfied customers who trust our services and trust our hard work with certainty. We are satisfied with our 99.9% customer satisfaction rate.
Contact us:-
Data Bridge Market Research
USA : +1 888 387 2818
UK: +44 208 089 1725
Hong Kong : +852 8192 7475
Email:– corporatesales@databridgemarketresearch.com
